Overview
Dr. Michael O’Leary is a senior urologic surgeon at Brigham and Women’s Hospital and professor of surgery at Harvard Medical School. A graduate of George Washington Medical Center, he completed his residency in urology at Massachusetts General Hospital and New England Medical Center, and his fellowship at the University of California, San Francisco School of Medicine. He is board certified in urology. Dr. O’Leary has been identified as one of America’s Top Urology Doctors by Castle Connolly and was named a top urologist by Boston Magazine.An active researcher, Dr. O’Leary has focused on the development and validation of hard measures of subjective outcomes in urologic disease. He has been an investigator in clinical trials for new modalities of therapy for erectile dysfunction. Dr. O’Leary’s current research includes benign prostatic hyperplasia (BPH) and male sexual dysfunction. His clinical specialties include: BPH, male infertility, male sexual dysfunction and stone disease.
Dr. O'leary is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Urachal Cyst, Peyronie Disease, Endoscopy, and Gallbladder Removal.
His clinical research consists of co-authoring 91 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1153 Centre Street, Suite 4S, Jamaica Plain, MA 02130
Additional Areas of Focus
Dr. O'leary has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy.
Brigham And Women's Faulkner Hospital, Department Of Urology
Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.
Dana-Farber Cancer Institute, Inc.
Adam Kibel is a Urologist in Boston, Massachusetts. Dr. Kibel is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Kibel is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Enlarged Prostate (BPH)Dr. O'leary isAdvanced. Learn about Enlarged Prostate (BPH).
- Peyronie DiseaseDr. O'leary isAdvanced. Learn about Peyronie Disease.
- Prostate CancerDr. O'leary isAdvanced. Learn about Prostate Cancer.
- Urachal CystDr. O'leary isAdvanced. Learn about Urachal Cyst.
- Experienced
- Bilateral HydronephrosisDr. O'leary isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. O'leary isExperienced. Learn about Bladder Cancer.
- Bladder Outlet ObstructionDr. O'leary isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder StonesDr. O'leary isExperienced. Learn about Bladder Stones.
- BoilsDr. O'leary isExperienced. Learn about Boils.
- CarbuncleDr. O'leary isExperienced. Learn about Carbuncle.